Polycystic ovary syndrome
Conditions
Interventions
Gold Standard:1. Sparse ovulation or anovulation
2. Clinical manifestations of high androgen and hyperandrogenism
3. Polycystic ovaries visualized through ultrasonography: one or both sides of the ovary with a diameter of 2-9 mm follicles >= 12 and / or ovarian volume >= 10 cm3.
Two of the above three articles we
Index test:Elecsys AMH
Sponsors
Beijing Obstetrics & Gynecology Hospital,Capital Medical university
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: 20-40 years old women of childbearing age 1. PCOS group: (1) Sparse ovulation or anovulation; (2) Clinical manifestations of high androgen and hyperandrogenism; (3) Polycystic ovaries visualized through ultrasonography: one or both sides of the ovary with a diameter of 2-9 mm follicles >= 12 and / or ovarian volume >= 10 cm3. Two of the above three articles were excluded, and other diseases causing hyperandrogen such as congenital adrenal hyperplasia and Cushing syndrome were excluded. It can be diagnosed as PCOS. 2. Normal control group: (1) Women who have been examined before pregnancy; (2) Regular menstruation, no history of PCOS.
Exclusion criteria
Exclusion criteria: (1) Currently treated with sex hormones within 3 months prior to enrollment (long-acting treatment for 6 months); (2) There are diseases related to coagulopathy; (3) Cushing's syndrome; (4) Functional uterine bleeding; (5) hypothalamic-pituitary amenorrhea; (6) hyperprolactinemia; (7) premature ovarian failure; (8) ovarian functional tumors; (9) ovarianhyperthecosis; (10) Other patients identified by the investigator as unsuitable for participation in the study; (11) Known or suspected pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| anti-Mullerian hormone; | — |
Countries
China
Contacts
Public ContactXiangyan Ruan
Beijing Obstetrics & Gynecology Hospital, Capital Medical university
Outcome results
None listed